The epidemiology of end-stage renal disease among African Americans

被引:75
作者
Martins, D
Tareen, N
Norris, KC
机构
[1] Charles R Drew Univ Med & Sci, Dept Internal Med, Los Angeles, CA 90059 USA
[2] Univ Calif Los Angeles, Sch Med, Dept Internal Med, Los Angeles, CA 90024 USA
[3] W Los Angeles Vet Adm Med Ctr, Los Angeles, CA USA
关键词
epidemiology; renal disease; end-stage renal disease (ESRD); African Americans; hypertension; diabetes;
D O I
10.1097/00000441-200202000-00002
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Although disparities in outcomes among African Americans compared with whites with respect to cardiovascular disease, cancer, diabetes, infant mortality, and other health standards have been well-described, these disparities are most dramatic with respect to kidney diseases. End-stage renal disease (ESRD) occurs almost 4 times more commonly in African Americans than in their white counterparts. These disparate rates of kidney disease may be caused by the complex interplay of genetic, environmental, cultural, and socioeconomic factors. African Americans are particularly vulnerable to the deleterious renal effects of hypertension and may require more aggressive blood pressure control than whites to accrue benefit with respect to preservation of renal function. Diabetes, the leading cause of ESRD in the United States, is another important factor in the excess renal morbidity and mortality of African Americans because of its prevalence in this population. Other renal diseases, especially those associated with HIV/AIDS, are also much more likely to affect African Americans than other American population subgroups. A more thorough understanding of the epidemiology of renal diseases in African Americans and the cultural, social, and biological differences that underlie racial disparities in prevalence of renal disease will be essential to the design of effective public health strategies for prevention and treatment of this burdensome problem.
引用
收藏
页码:65 / 71
页数:7
相关论文
共 44 条
[1]
[Anonymous], 1997, ARCH INTERN MED, V157, P2413, DOI DOI 10.1001/ARCHINTE.1997.00440420033005
[2]
[Anonymous], 2000, Lancet, V355, P253, DOI DOI 10.1016/S0140-6736(99)12323-7
[3]
Calcium channel blockers versus other antihypertensive therapies on progression of NIDDM associated nephropathy [J].
Bakris, GL ;
Copley, JB ;
Vicknair, N ;
Sadler, R ;
Leurgans, S .
KIDNEY INTERNATIONAL, 1996, 50 (05) :1641-1650
[4]
Preserving renal function in adults with hypertension and diabetes: A consensus approach [J].
Bakris, GL ;
Williams, M ;
Dworkin, L ;
Elliott, WJ ;
Epstein, M ;
Toto, R ;
Tuttle, K ;
Douglas, J ;
Hsueh, W ;
Sowers, J .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 36 (03) :646-661
[5]
Should all patients with type 1 diabetes mellitus and microalbuminuria receive angiotensin-converting enzyme inhibitors? A meta-analysis of individual patient data [J].
Chaturvedi, N .
ANNALS OF INTERNAL MEDICINE, 2001, 134 (05) :370-379
[6]
Prevalence of high blood pressure and elevated serum creatinine level in the United States -: Findings from the Third National Health and Nutrition Examination Survey (1988-1994) [J].
Coresh, J ;
Wei, L ;
McQuillan, G ;
Brancati, FL ;
Levey, AS ;
Jones, C ;
Klag, MJ .
ARCHIVES OF INTERNAL MEDICINE, 2001, 161 (09) :1207-1216
[7]
ATTRIBUTABLE RISK, POPULATION ATTRIBUTABLE RISK, AND POPULATION ATTRIBUTABLE FRACTION OF DEATH ASSOCIATED WITH HYPERTENSION IN BIRACIAL POPULATION [J].
DEUBNER, DC ;
TYROLER, HA ;
CASSEL, JC ;
HAMES, CG ;
BECKER, C .
CIRCULATION, 1975, 52 (05) :901-908
[8]
Diabet Control Complications DCCT Res Grp, 1995, KIDNEY INT, V47, P1703
[9]
EASTERLING RE, 1977, T AM SOC ART INT ORG, V23, P28
[10]
Egger M, 1997, DIABETIC MED, V14, P919, DOI 10.1002/(SICI)1096-9136(199711)14:11<919::AID-DIA456>3.0.CO